Trials / Conditions / New Onset Atrial Fibrillation

New Onset Atrial Fibrillation

9 registered clinical trials studyying New Onset Atrial Fibrillation — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients NCT05829317	Dr. Stephanie Sibley	Phase 4
Completed	New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China NCT05511649	Shanghai 10th People's Hospital	—
Recruiting	Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery NCT05169866	Beijing Anzhen Hospital	Phase 3
Recruiting	Tracking Atrial Fibrillation After Intensive Care Admission NCT05229211	University of Oxford	—
Completed	Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery NCT04472299	University of Minnesota	Phase 4
Unknown	Rapid Atrial Fibrillation Treatment Strategy NCT04092621	Our Lady of the Lake Hospital	Phase 4
Unknown	Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring NCT04038944	St. Francis Hospital, New York	—
Completed	Management of Paroxystic Atrial Fibrillation in French Intensive Care Units NCT03977883	University Hospital, Clermont-Ferrand	—
Terminated	Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock NCT02668432	The University of Texas Health Science Center at San Antonio	Phase 4